DiaMedica Therapeutics
DMAC
DMAC
78 hedge funds and large institutions have $82.8M invested in DiaMedica Therapeutics in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
23% more call options, than puts
Call options by funds: $178K | Put options by funds: $145K
4.24% more ownership
Funds ownership: 20.44% → 24.68% (+4.2%)
Holders
78
Holding in Top 10
1
Calls
$178K
Puts
$145K
Top Buyers
| 1 | +$8.74M | |
| 2 | +$8.16M | |
| 3 | +$3.34M | |
| 4 |
Morgan Stanley
New York
|
+$2.33M |
| 5 |
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Dallas,
Texas
|
+$1.55M |
Top Sellers
| 1 | -$5.98M | |
| 2 | -$697K | |
| 3 | -$241K | |
| 4 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$207K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$156K |
